Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$5.14bn897.23n/a
au flag iconCU6Clarity PharmaceuticalsAU$1.18bnn/an/a
au flag iconMSBMesoblastAU$1.17bnn/an/a
au flag iconIMMImmutepAU$534.98mn/an/a
au flag iconIMUImugeneAU$509.01mn/an/a
au flag iconPYCPYC TherapeuticsAU$429.28mn/an/a
au flag iconOPTOptheaAU$407.63mn/an/a
au flag iconRACRace OncologyAU$238.70mn/an/a
au flag iconCGSCogstateAU$212.50m27.76n/a
au flag iconDXBDimerixAU$181.13mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$126.62mn/an/a
au flag iconALAArovella TherapeuticsAU$109.16mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$93.15mn/an/a
au flag iconOCCOrthocellAU$72.73mn/an/a
au flag iconAGNArgenica TherapeuticsAU$69.90mn/an/a
au flag iconLTPLtr PharmaAU$66.92mn/an/a
au flag iconACWActinogen MedicalAU$67.02mn/an/a
au flag iconNTINeurotech InternationalAU$65.99mn/an/a
au flag iconPERPercheron TherapeuticsAU$64.91mn/an/a
au flag iconADOAnteotechAU$52.71mn/an/a